Apogee Therapeutics, Inc. (APGE)
Biological Products, (No Diagnostic Substances)
Latest Price
$135.07
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
87.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 8.49M | $1.13B | 11.27% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.51M | $730.0M | 7.31% | +1.42M | 2026-06-30 |
| HBK INVESTMENTS L P | 2.85M | $378.0M | 3.78% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.57M | $341.0M | 3.41% | +70.0K | 2026-06-30 |
| FMR LLC | 2.49M | $330.0M | 3.31% | -6.77M | 2026-06-30 |
| STATE STREET CORP | 2.30M | $304.0M | 3.05% | +134.8K | 2026-06-30 |
| Balyasny Asset Management L.P. | 2.17M | $287.0M | 2.87% | +1.73M | 2026-06-30 |
| Driehaus Capital Management LLC | 1.74M | $230.0M | 2.31% | -180.7K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1.69M | $224.0M | 2.25% | +1.04M | 2026-06-30 |
| GLAZER CAPITAL, LLC | 1.64M | $217.0M | 2.18% | -- | 2026-06-30 |